tiprankstipranks

John F. Milligan Insider Profile

11 Followers
John F. Milligan, President & CEO, Director at Gilead Sciences, holds 132.82K shares in Pacific Biosciences (Ticker: PACB), holds 100.00K shares in 4D Molecular Therapeutics (Ticker: FDMT), holds 1.57M shares in Gilead Sciences (Ticker: GILD).
tipranks
John F. Milligan

John F. Milligan
Gilead Sciences (GILD)
President & CEO, Director

Ranked #5,856 out of 98,042 Corporate Insiders

Profitable Transactions

82%
18 out of 22 Profitable Transactions

Average Return

+13.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$116M
98.57%
1.24%
0.19%
A breakdown of John F. Milligan's holdings

Insider Roles

Gilead Sciences
(GILD)
President & CEO, Director
4D Molecular Therapeutics
(FDMT)
Director
Pacific Biosciences
(PACB)
Director
Roles that John F. Milligan holds in companies

Most Profitable Insider Trade

Stock:
Gilead Sciences
(GILD)
Rating:Informative Buy
Date:May 09, 2014 - May 09, 2015
Return:+35.60%
The most profitable trade made by John F. Milligan

John F. Milligan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Gilead Sciences
Nov 29, 2018
President & CEO, Director
Uninformative Buy
6.61M
$114.23M
4D Molecular Therapeutics
Dec 17, 2020
Director
Informative Buy
2.30M
$1.44M
Pacific Biosciences
Jun 20, 2024
Director
Uninformative Buy
$220.48K
List of latest transactions for each holding click on a transaction to see John F. Milligan's performance on stock

John F. Milligan insider profile FAQ

What is the percentage of profitable transactions made by John F. Milligan?
The percentage of profitable transactions made by John F. Milligan is 82%.
    What is the average return per transaction made by John F. Milligan?
    The average return per transaction made by John F. Milligan is 13.20%.
      What stocks does John F. Milligan hold?
      John F. Milligan holds: GILD, FDMT, PACB stocks.
        What was John F. Milligan’s latest transaction?
        John F. Milligan latest transaction was an Uninformative Buy of ―.
          What was John F. Milligan's most profitable transaction?
          John F. Milligan’s most profitable transaction was an Informative Buy of GILD stock on May 9, 2014. The return on the trade was 35.60%.
            What is John F. Milligan's role in Gilead Sciences?
            John F. Milligan's role in Gilead Sciences is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.